Lipidomics Workflow for Analyzing Lipid Profiles Using Multiple Reaction Monitoring (MRM) in Liver Homogenate of Mice with Non-alcoholic Steatohepatitis (NASH)

被引:1
作者
Wee, Hai Ning [1 ]
Lee, Lye Siang [1 ]
Hong, Sharon [1 ]
Han, Yu [1 ]
Zhou, Jin [1 ]
Yen, Paul Michael [1 ]
Ching, Jianhong [1 ,2 ]
机构
[1] Duke NUS Med Sch, Cardiovasc & Metab Disorders Programme, Singapore, Singapore
[2] KK Womens & Childrens Hosp, Res Ctr, Singapore, Singapore
来源
BIO-PROTOCOL | 2023年 / 13卷 / 13期
基金
英国医学研究理事会;
关键词
Lipidomics; Liver; LC-MS; Sphingolipids; Fatty acids; Glycerolipids; Phospholipids; Cholesteryl esters;
D O I
10.21769/BioProtoc.4773
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Non-alcoholic steatohepatitis (NASH) is a condition characterized by inflammation and hepatic injury/fibrosis caused by the accumulation of ectopic fats in the liver. Recent advances in lipidomics have allowed the identification and characterization of lipid species and have revealed signature patterns of various diseases. Here, we describe a lipidomics workflow to assess the lipid profiles of liver homogenates taken from a NASH mouse model. The protocol described below was used to extract and analyze the metabolites from the livers of mice with NASH by liquid chromatography-mass spectrometry (LC-MS); however, it can be applied to other tissue homogenate samples. Using this method, over 1,000 species of lipids from five classes can be analyzed in a single run on the LC-MS. Also, partial elucidation of the identity of neutral lipid (triacylglycerides and diacylglycerides) aliphatic chains can be performed with this simple LC-MS setup.
引用
收藏
页数:13
相关论文
共 2 条
  • [1] Pseudotargeted lipidomics analysis of scoparone on glycerophospholipid metabolism in non-alcoholic steatohepatitis mice by LC-MRM-MS
    Song, Qi
    Zhao, Ziyi
    Liu, Hu
    Zhang, Jinling
    Wang, Zhiqiang
    Zhang, Yunqi
    Ma, Guowei
    Ge, Shaoqin
    PEERJ, 2024, 12
  • [2] Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
    Elbadawy, Mohamed
    Tanabe, Kiwamu
    Yamamoto, Haru
    Ishihara, Yusuke
    Mochizuki, Maria
    Abugomaa, Amira
    Yamawaki, Hideyuki
    Kaneda, Masahiro
    Usui, Tatsuya
    Sasaki, Kazuaki
    FRONTIERS IN PHARMACOLOGY, 2023, 14